Accession Number: | 0001179110-14-013435 |
Date: | 2014-08-27 |
Issuer: | SUNESIS PHARMACEUTICALS INC (SNSS) |
Original Submission Date: |
SWISHER DANIEL N JR
C/O SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BLVD., STE. 400
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-08-27 | M | 5,000 | a | $2.09 | 159,073 | direct | ||
COMMON STOCK | 2014-08-27 | S | 5,000 | d | $8.00 | 154,073 | direct | ||
COMMON STOCK | 2014-08-27 | 0 | $0.00 | 129,136 | indirect | f3 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.09 | 2014-08-27 | deemed execution date | M | 5,000 (d) | 2021-06-29 | common stock 5,000 | $2.09 | 710,611 | direct |
ID | footnote |
---|---|
f1 | the number of shares includes 1,667 shares that the reporting person acquired from an espp purchase on may 30, 2014. |
f2 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 10, 2013. |
f3 | the shares are held by the swisher revocable trust for which reporting person is the trustee. |
f4 | one forty-eighth (1/48th) of the shares vest monthly from 6/30/11. |